Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Evans

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Pain|May 15, 2025
Chronic pain selectively reduces the motivation to work for remifentanil but not food rewardLindsay Lueptow, Leeza Shashkova, Emma Twombly, et al.
Pain|August 21, 2025
Chronic pain selectively reduces the motivation to work for remifentanil but not food rewardLindsay Lueptow, Leeza Shashkova, Emma Twombly, et al.
Headache|December 28, 2021
Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine DiaryRichard B Lipton, Pranav Gandhi, Jonathan Stokes, et al.
Headache|January 5, 2011
Key concepts of migraine postdrome: a qualitative study to develop a post-migraine questionnaireDaisy S Ng-Mak, Kristina A Fitzgerald, Josephine M Norquist, et al.
The Journal of Pain|June 27, 2025
Opposing effects of mu opioid receptors on dopamine D1 and D2 receptor expressing neurons in opioid mediated antinociceptionJacob Alderete, Anthony Tanzillo, Jason Miller, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 14, 2003
Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptorsKabirullah Lutfy, Shoshana Eitan, Camron D Bryant, et al.
JACS Au|October 31, 2025
An Orally Administered Misuse Deterrent Opioid Prodrug for Treatment of Acute PainDouglas A Rose, Joseph W Treacy, Karina Seth, et al.
Addiction Biology|June 27, 2022
Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trialErica N Grodin, Steven J Nieto, Lindsay R Meredith, et al.
Journal of the American Medical Directors Association|February 22, 2011
Development of a new patient-reported outcome measure in sarcopeniaChristopher J Evans, Chiun-Fang Chiou, Kristina A Fitzgerald, et al.
Journal of Child and Adolescent Psychopharmacology|August 2, 2019
A Novel Assessment Tool for Impulsive Aggression in Children with Attention-Deficit/Hyperactivity DisorderGianpiera Ceresoli-Borroni, Tesfaye Liranso, Scott T Brittain, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Pain|May 15, 2025
Chronic pain selectively reduces the motivation to work for remifentanil but not food rewardLindsay Lueptow, Leeza Shashkova, Emma Twombly, et al.
Pain|August 21, 2025
Chronic pain selectively reduces the motivation to work for remifentanil but not food rewardLindsay Lueptow, Leeza Shashkova, Emma Twombly, et al.
Headache|December 28, 2021
Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine DiaryRichard B Lipton, Pranav Gandhi, Jonathan Stokes, et al.
Headache|January 5, 2011
Key concepts of migraine postdrome: a qualitative study to develop a post-migraine questionnaireDaisy S Ng-Mak, Kristina A Fitzgerald, Josephine M Norquist, et al.
The Journal of Pain|June 27, 2025
Opposing effects of mu opioid receptors on dopamine D1 and D2 receptor expressing neurons in opioid mediated antinociceptionJacob Alderete, Anthony Tanzillo, Jason Miller, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 14, 2003
Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptorsKabirullah Lutfy, Shoshana Eitan, Camron D Bryant, et al.
JACS Au|October 31, 2025
An Orally Administered Misuse Deterrent Opioid Prodrug for Treatment of Acute PainDouglas A Rose, Joseph W Treacy, Karina Seth, et al.
Addiction Biology|June 27, 2022
Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trialErica N Grodin, Steven J Nieto, Lindsay R Meredith, et al.
Journal of the American Medical Directors Association|February 22, 2011
Development of a new patient-reported outcome measure in sarcopeniaChristopher J Evans, Chiun-Fang Chiou, Kristina A Fitzgerald, et al.
Journal of Child and Adolescent Psychopharmacology|August 2, 2019
A Novel Assessment Tool for Impulsive Aggression in Children with Attention-Deficit/Hyperactivity DisorderGianpiera Ceresoli-Borroni, Tesfaye Liranso, Scott T Brittain, et al.
Pageof 10